Sab Biotherapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Sab Biotherapeutics (SABSW) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Sab Biotherapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $4.9k | 146k | 0.03 |
| 2024-12-31 | $11k | 146k | 0.08 |
| 2024-09-30 | $5.3k | 146k | 0.04 |
| 2024-06-30 | $6.9k | 146k | 0.05 |
| 2024-03-31 | $4.5k | 149k | 0.03 |
| 2023-12-31 | $4.5k | 149k | 0.03 |
| 2023-09-30 | $10k | 149k | 0.07 |
| 2023-06-30 | $16k | 149k | 0.10 |
| 2022-12-31 | $7.0k | 149k | 0.05 |
| 2022-06-30 | $22k | 149k | 0.15 |
| 2022-03-31 | $72k | 151k | 0.48 |